Back
TransCode Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
RNAZ
TransCode Therapeutics, Inc.
Last Price:
$8.57
Seasonality Move:
-17.07%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAZ is experiencing selling pressure, which indicates risk of future bearish movement.
TransCode Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.6 | Buy |
| 20-day SMA: | 9.14 | Sell |
| 50-day SMA: | 9.59 | Sell |
| 200-day SMA: | 9.88 | Sell |
| 8-day EMA: | 8.71 | Sell |
| 20-day EMA: | 9.01 | Sell |
| 50-day EMA: | 9.25 | Sell |
| 200-day EMA: | 561.39 | Sell |
TransCode Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 41.02 | Sell |
| Chaikin Money Flow: | -1539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.73 - 9.79) | Sell |
| Bollinger Bands (100): | (8.03 - 10.03) | Sell |
TransCode Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for TransCode Therapeutics, Inc. Stock
Is TransCode Therapeutics, Inc. Stock a Buy?
-
TransCode Therapeutics, Inc. share price is 8.60 while RNAZ 8-day simple moving average is 8.60, which is a Buy signal.
-
The stock price of RNAZ is 8.60 while TransCode Therapeutics, Inc. 20-day SMA is 9.14, which makes it a Sell.
-
TransCode Therapeutics, Inc. 50-day simple moving average is 9.59 while RNAZ share price is 8.60, making it a Sell technically.
-
RNAZ stock price is 8.60 and TransCode Therapeutics, Inc. 200-day simple moving average is 9.88, creating a Sell signal.
RNAZ Technical Analysis vs Fundamental Analysis
Sell
36
TransCode Therapeutics, Inc. (RNAZ)
is a Sell
Is TransCode Therapeutics, Inc. a Buy or a Sell?
-
TransCode Therapeutics, Inc. stock is rated a SellThe current TransCode Therapeutics, Inc. [RNAZ] share price is $8.60. The Score for RNAZ is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
TransCode Therapeutics, Inc. Stock Info
Market Cap:
7.1M
Price in USD:
8.60
Share Volume:
1.5K
TransCode Therapeutics, Inc. 52-Week Range
52-Week High:
22.03
52-Week Low:
6.08
Sell
36
TransCode Therapeutics, Inc. (RNAZ)
is a Sell
TransCode Therapeutics, Inc. Share Price Forecast
-
What is the TransCode Therapeutics, Inc. stock price today?The TransCode Therapeutics, Inc. stock price is 8.60 USD today.
-
Will RNAZ stock go up or go down?TransCode Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is TransCode Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, TransCode Therapeutics, Inc. is overvalued.
Is TransCode Therapeutics, Inc. Stock a Buy?
-
TransCode Therapeutics, Inc. share price is 8.60 while RNAZ 8-day exponential moving average is 8.71, which is a Sell signal.
-
The stock price of RNAZ is 8.60 while TransCode Therapeutics, Inc. 20-day EMA is 9.01, which makes it a Sell.
-
TransCode Therapeutics, Inc. 50-day exponential moving average is 9.25 while RNAZ share price is 8.60, making it a Sell technically.
-
RNAZ stock price is 8.60 and TransCode Therapeutics, Inc. 200-day simple moving average is 561.39, creating a Sell signal.
Fundamental Analysis of TransCode Therapeutics, Inc.
Is TransCode Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and a decrease next year of $0.00 per share.
Technical Analysis of TransCode Therapeutics, Inc.
Should I short TransCode Therapeutics, Inc. stock?
-
RNAZ Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting TransCode Therapeutics, Inc. is a Sell
-
TransCode Therapeutics, Inc. Relative Strength Index (RSI) is 41.02, which suggest TransCode Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for TransCode Therapeutics, Inc. is (8.73 - 9.79), which suggest TransCode Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for TransCode Therapeutics, Inc. is (8.03 - 10.03), which suggest TransCode Therapeutics, Inc. is a Sell
* TransCode Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.